Deferred Tax Assets and Other Non-Current Assets
Idexx Laboratories Deferred Tax Assets and Other Non-Current Assets increased by 1.9% to $552.79M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.0%, from $547.56M to $552.79M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows an upward trend with a 13.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase generally suggests the accumulation of long-term economic benefits or tax recovery potential.
Detailed definition
This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets that do not...
Peer comparison
Varies widely based on the specific composition of 'other' assets, making it a general indicator of long-term asset health.
deferred_tax_assets_other_noncurrentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $305.35M | $317.14M | $330.40M | $335.57M | $398.55M | $403.44M | $417.73M | $421.15M | $439.23M | $448.40M | $496.53M | $498.91M | $539.72M | $559.27M | $547.52M | $547.56M | $580.77M | $513.57M | $542.48M | $552.79M |
| QoQ Change | — | +3.9% | +4.2% | +1.6% | +18.8% | +1.2% | +3.5% | +0.8% | +4.3% | +2.1% | +10.7% | +0.5% | +8.2% | +3.6% | -2.1% | +0.0% | +6.1% | -11.6% | +5.6% | +1.9% |
| YoY Change | — | — | — | — | +30.5% | +27.2% | +26.4% | +25.5% | +10.2% | +11.1% | +18.9% | +18.5% | +22.9% | +24.7% | +10.3% | +9.8% | +7.6% | -8.2% | -0.9% | +1.0% |
Deferred Tax Assets and Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's deferred tax assets and other non-current assets?
- Idexx Laboratories (IDXX) reported deferred tax assets and other non-current assets of $552.79M in Q1 2026.
- How has Idexx Laboratories's deferred tax assets and other non-current assets changed year-over-year?
- Idexx Laboratories's deferred tax assets and other non-current assets increased by 1.0% year-over-year, from $547.56M to $552.79M.
- What is the long-term trend for Idexx Laboratories's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Idexx Laboratories's deferred tax assets and other non-current assets has grown at a 13.4% compound annual growth rate (CAGR), from $289.60M to $542.48M.
- What does deferred tax assets and other non-current assets mean?
- The combined value of long-term tax assets and other miscellaneous long-term assets.